GL
CVS icon

Graypoint LLC’s CVS Health CVS Stock Holding History

Graypoint LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$688K Sell
9,973
-25
-0.3% -$1.64K 0.04% 272
2025
Q1 		$677K Buy
9,998
+4,811
+93% +$288K 0.04% 267
2024
Q4 		$233K Buy
5,187
+683
+15% +$38.3K 0.01% 466
2024
Q3 		$283K Sell
4,504
-324
-7% -$18.9K 0.02% 411
2024
Q2 		$285K Sell
4,828
-5,915
-55% -$370K 0.02% 391
2024
Q1 		$857K Buy
10,743
+2,897
+37% +$221K 0.06% 195
2023
Q4 		$620K Sell
7,846
-1,184
-13% -$84.3K 0.05% 223
2023
Q3 		$630K Sell
9,030
-276
-3% -$19.6K 0.06% 203
2023
Q2 		$643K Buy
9,306
+780
+9% +$55.5K 0.06% 184
2023
Q1 		$634K Buy
8,526
+1,340
+19% +$112K 0.07% 176
2022
Q4 		$670K Sell
7,186
-702
-9% -$67.7K 0.08% 164
2022
Q3 		$752K Buy
7,888
+1,714
+28% +$170K 0.1% 144
2022
Q2 		$572K Sell
6,174
-1,736
-22% -$169K 0.07% 164
2022
Q1 		$801K Buy
7,910
+2,765
+54% +$290K 0.08% 155
2021
Q4 		$531K Buy
5,145
+649
+14% +$60K 0.06% 191
2021
Q3 		$381K Buy
4,496
+156
+4% +$13.1K 0.05% 196
2021
Q2 		$362K Buy
4,340
+533
+14% +$43.6K 0.05% 193
2021
Q1 		$286K Sell
3,807
-154
-4% -$11.2K 0.04% 195
2020
Q4 		$271K Sell
3,961
-1,657
-29% -$108K 0.05% 186
2020
Q3 		$328K Sell
5,618
-15,381
-73% -$957K 0.06% 156
2020
Q2 		$1.36M Buy
20,999
+1,583
+8% +$99.7K 0.31% 76
2020
Q1 		$1.15M Buy
+19,416
New +$1.3M 0.32% 71

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Graypoint LLC's CVS Position: Q2 2025 in Review

Graypoint LLC reduced its CVS Health (CVS) stake by 0.25% in Q2 2025, selling an estimated $1.64K and leaving 9,973 shares worth $688K. The position accounts for 0.04% of the portfolio, ranked #272.

Graypoint LLC first reported a position in CVS in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.36M in Q2 2020. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Graypoint LLC held 9,973 shares of CVS Health worth $688K as of Q2 2025.
  • Graypoint LLC sold 25 CVS Health shares in Q2 2025, an estimated $1.64K.
  • CVS Health made up 0.04% of Graypoint LLC's portfolio in Q2 2025, its #272 holding.
  • Graypoint LLC first reported a position in CVS Health in Q1 2020 and has held it in 22 quarters since.
  • Graypoint LLC's CVS Health position peaked at $1.36M in Q2 2020.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.